Compare
Abbott Laboratories vs Zimmer Biomet (ABT vs ZBH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Zimmer Biomet (ZBH) +20.6%; so far this year the figures are -12.3% and +17.4%.
Abbott Laboratories is the larger company by market value, about 9.5 times the size of Zimmer Biomet.
On trailing earnings, ABT trades at 40.9 times and ZBH at 26.7 times.
Revenue grew +10.0% at ABT and +7.0% at ZBH over the last year.
ABT yields 2.29%. ZBH yields 0.91%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | ZBH | |
|---|---|---|
| Price | $109.93 | $105.59 |
| 1-day | -3.23% | -1.18% |
| YTD | -12.26% | +17.43% |
| 1 year | -11.73% | +20.61% |
| 3 years | +15.70% | +0.49% |
| Market cap | $190.4B | $20.0B |
| P/E | 40.9 | 26.7 |
| P/S | 3.95 | 2.33 |
| P/B | 3.73 | 1.57 |
| Revenue growth | +10.00% | +7.00% |
| EPS growth | -66.20% | -1.70% |
| Gross margin % | 56.9 | 69.7 |
| Net margin % | 9.7 | 9.0 |
| ROE % | 9.2 | 6.0 |
| Debt / equity | 0.61 | 0.59 |
| FCF yield % | 3.5 | 8.2 |
| Dividend yield % | 2.29 | 0.91 |
| Beta | 0.06 | 0.36 |
| RSI (14) | 58.5 | 64.2 |
| Technical rating |